Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mycobacterium tuberculosis is the causative agent of tuberculosis (TB). It is a slow-growing bacterium with a unique waxy cell wall rich in mycolic acids. It primarily infects the lungs but can affect other organs. Infection occurs via inhalation of airborne droplets. Treatment involves antibiotics, but drug resistance is a major challenge.
Antibiotics like isoniazid and ethambutol target cell wall synthesis and other mechanisms within M. tuberculosis to inhibit its growth and replication.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mycobacterium tuberculosis (M. tuberculosis).